OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
2
Results
Show all
Save search
Copy query
Show results for
Proteomics
(2)
Organisms
Andropogon gerardi
(2)
Bacteria
(2)
Borrelia
(2)
Botrytis cinerea
(2)
Candida albicans
(2)
Canis lupus familiaris
(2)
Clostridium perfringens
(2)
Cnidaria
(2)
Eukaryota
(2)
Fasciola
(2)
Fungi
(2)
Hepatitis B virus
(2)
Human betaherpesvirus 5
(2)
Influenza C virus
(2)
Japanese encephalitis virus group
(2)
Miscanthus x giganteus
(2)
Mycobacterium tuberculosis
(2)
Orthoflavivirus
(2)
Panicum virgatum
(2)
Platyhelminthes
(2)
Pseudomonas aeruginosa AES-1R
(2)
Rickettsia
(2)
Saccharomyces cerevisiae
(2)
Schizosaccharomyces pombe
(2)
Severe acute respiratory syndrome coronavirus 2
(2)
Shigella
(2)
Sorghastrum nutans
(2)
Streptococcus pneumoniae
(2)
Toxoplasma gondii
(2)
Tripsacum dactyloides
(2)
Repository
pride
(2)
Tissue
Blood serum
(2)
Disease
Acute leukemia
(2)
Breast cancer
(2)
Non-small cell lung carcinoma
(2)
Technology Type
Affinity purification coupled with mass spectrometry proteomics
(2)
Mass Spectrometry
(2)
Publication Date
2015
(2)
Lab affiliation
Cell Signaling Technology
(2)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Serum PTM Identification_Technical Triplicates
A technical triplicate experiment was performed to validate the robustness of the method using pooled serum of non-small cell lung cancer patients
ORGANISM(S):
Homo sapiens (Human)
2015-12-07
|
PXD002931
|
Pride
Ptm
Cancer serum
Cite
Cancer Serum PTM Profiling - Quantitative profiling of post-translational modifications by immunoaffinity enrichment and LC-MS/MS in cancer serum without immunodepletion
Quantitative profiling study of post-translational modifications was done by using antibody based enrichment and LC-MS/MS
ORGANISM(S):
Homo sapiens (Human)
2015-12-07
|
PXD002932
|
Pride
Cancer serum
Ptm
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
